Eymen Gazel1, Engin Kaya2, Serdar Yalcin3, Halil Çagri Aybal4, Tahsin Batuhan Aydogan5, Lutfi Tunc6. 1. Department of Urology, Acıbadem University Ankara Hospital, Ankara, Turkey. 2. Department of Urology, Health Science University Gulhane Training and Research Hospital, Ankara, Turkey, drenginkaya@yahoo.com. 3. Department of Urology, Health Science University Gulhane Training and Research Hospital, Ankara, Turkey. 4. Department of Urology, Ankara Oncology Training and Research Hospital, Ankara, Turkey. 5. Department of Urology, Kahramanmaraş Goksun State Hospital, Kahramanmaraş, Turkey. 6. Department of Urology, Gazi University School of Medicine, Ankara, Turkey.
Abstract
INTRODUCTION: Holmium laser enucleation of the prostate (HoLEP) is becoming the new standard procedure for treating benign prostatic hyperplasia (BPH), a common condition in aging men. Most studies have focused on proving its efficacy in treating large prostates. In this study, we compared its efficacy in treating small (< 80 mL) and large (> 80 mL) prostates. METHODS: This prospective study included 119 patients with BPH who underwent HoLEP by the same surgeon between June 2015 and December 2017. They were divided into 2 groups according to their prostate volumes (≤80 mL: Group 1; > 80 mL: Group 2). Various pre- and postoperative parameters were compared within and between the groups. RESULTS: International Prostate Symptom Score (IPSS), postvoid residual (PVR) volume, and voiding time (VT) significantly decreased, and the peak urinary flow rate (Qmax), average urinary flow rate (Qave), and quality of life (QoL) score significantly increased postoperatively in both groups. The postoperative changes in IPSS, QoL score, Qmax, Qave, VT, PVR volume, and hemoglobin levels were not significantly different between the groups. In addition, no significant difference was observed in postoperative complications between the groups. CONCLUSIONS: Our results indicate that HoLEP is an effective procedure for treating both small and large prostates.
INTRODUCTION:Holmium laser enucleation of the prostate (HoLEP) is becoming the new standard procedure for treating benign prostatic hyperplasia (BPH), a common condition in aging men. Most studies have focused on proving its efficacy in treating large prostates. In this study, we compared its efficacy in treating small (< 80 mL) and large (> 80 mL) prostates. METHODS: This prospective study included 119 patients with BPH who underwent HoLEP by the same surgeon between June 2015 and December 2017. They were divided into 2 groups according to their prostate volumes (≤80 mL: Group 1; > 80 mL: Group 2). Various pre- and postoperative parameters were compared within and between the groups. RESULTS: International Prostate Symptom Score (IPSS), postvoid residual (PVR) volume, and voiding time (VT) significantly decreased, and the peak urinary flow rate (Qmax), average urinary flow rate (Qave), and quality of life (QoL) score significantly increased postoperatively in both groups. The postoperative changes in IPSS, QoL score, Qmax, Qave, VT, PVR volume, and hemoglobin levels were not significantly different between the groups. In addition, no significant difference was observed in postoperative complications between the groups. CONCLUSIONS: Our results indicate that HoLEP is an effective procedure for treating both small and large prostates.
Authors: Nicholas E Boxall; Fanourios Georgiades; Saiful Miah; Laurian Dragos; James Armitage; Tevita F Aho Journal: World J Urol Date: 2021-05-12 Impact factor: 4.226
Authors: Bernd Rosenhammer; Maximilian Schönhärl; Roman Mayr; Marco J Schnabel; Maximilian Burger; Christian Eichelberg Journal: Urol Int Date: 2020-09-02 Impact factor: 2.089
Authors: Sercan Yılmaz; Engin Kaya; Eymen Gazel; Serdar Yalcın; Halil Cagrı Aybal; Mehmet Yılmaz; Onur Açıkgöz; Hakan Özdemir; Lutfi Tunc Journal: World J Urol Date: 2020-11-13 Impact factor: 4.226